Comparison between Claris Lifesciences IPO and Gravita India IPO.
Claris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Gravita India IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Claris Lifesciences IPO is up to ₹300.00 Cr whereas the issue size of the Gravita India IPO is up to ₹45.00 Cr. The final issue price of Claris Lifesciences IPO is ₹228.00 per share and of Gravita India IPO is ₹125.00 per share.
| Claris Lifesciences IPO | Gravita India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹228.00 per share | ₹120.00 per share |
| Issue Price (Upper) | ₹235.00 per share | ₹125.00 per share |
| Issue Price (Final) | ₹228.00 per share | ₹125.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 22 shares | 50 shares |
| Fresh Issue Size | 1,26,32,477 shares | 36,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹45.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,26,32,477 shares | 36,00,000 shares |
| Issue Size Total (Amount) | up to ₹300.00 Cr | up to ₹45.00 Cr |
Claris Lifesciences IPO opens on Nov 24, 2010, while Gravita India IPO opens on Nov 01, 2010. The closing date of Claris Lifesciences IPO and Gravita India IPO is Dec 02, 2010, and Nov 03, 2010, respectively.
| Claris Lifesciences IPO | Gravita India IPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2010 | |
| Issue Open | Nov 24, 2010 | Nov 01, 2010 |
| Issue Close | Dec 02, 2010 | Nov 03, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 20, 2010 | Nov 16, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Claris Lifesciences IPO P/E ratio is , as compared to Gravita India IPO P/E ratio of .
| Claris Lifesciences IPO | Gravita India IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 86.03 | 99.94 | ||||
| Promoter Shareholding (Post-Issue) | 0.69 | 73.52 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1455.05 Cr. | ₹170.25 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.15 | 49.71 |
In the Claris Lifesciences IPO Retail Individual Investors (RII) are offered 37,89,743 shares while in Gravita India IPO retail investors are offered 37,89,743 shares. Qualified Institutional Buyers (QIB) are offered 57,36,484 shares in Claris Lifesciences IPO and 17,75,000 shares in Gravita India IPO.
| Claris Lifesciences IPO | Gravita India IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,43,003 shares | |
| Market Maker Reservation | ||
| QIB | 57,36,484 shares | 17,75,000 shares |
| NII | 12,63,247 shares | 5,32,500 shares |
| RII | 37,89,743 shares | 12,42,500 shares |
| Employee | 50,000 shares | |
| Others | ||
| Total | 1,26,32,477 shares | 36,00,000 shares |
Claris Lifesciences IPO subscribed 1.05x in total, whereas Gravita India IPO subscribed 42.88x.
| Claris Lifesciences IPO | Gravita India IPO | |
|---|---|---|
| QIB (times) | 1.04x | 6.04x |
| NII (times) | 1.72x | 182.52x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.35x | 37.34x |
| Employee (times) | 1.17x | |
| Other (times) | ||
| Total (times) | 1.05x | 42.88x |
